Observational studyAmerican journal of respiratory and critical care medicine2024
Open access · greenAbstract readObservational StudyMulticenter Study
In one paragraph
Observational study in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 11 citations in OpenAlex.
- The Acute Respiratory Distress Syndrome (ARDS): epidemiology, etiology, molecular mechanisms, diagnosis and therapeutic strategies.Molecular biomedicine · 2026Review
- The role of SDF_1α/CXCR4 axis in non-antibody mediated TRALI in cardiac surgery patients.Intensive care medicine experimental · 2026Article
- Circ-PRKCI attenuates acute lung injury secondary to sepsis by targeting the miR-106b-5p/GAB1 axis.European journal of medical research · 2026Article
- Lipid metabolism-related genes regulate the immune microenvironment during ex vivo lung perfusion for lung transplants.Journal of thoracic disease · 2025Article
- MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injury.JCI insight · 2025Article
- Effect of pirfenidone on pulmonary fibrosis in acute lung injury via the regulation of the miR-34a-5p/TGF-β1/SMAD pathway.Journal of thoracic disease · 2025Article
- NKG2D blockade impairs tissue-resident memory T cell accumulation and reduces chronic lung allograft dysfunction.JCI insight · 2025Article
- CD94The European respiratory journal · 2024Article
- Natural Killer Cell Ligands: Another Source of Heterogeneity in Acute Lung Injury Pathophysiology?American journal of respiratory and critical care medicine · 2024Article
Corrections and comments
- Commented on by
Authors and funding
19 authors at 7 institutions in 4 countries.
Oscar A AguilarDepartment Microbiology and Immunology.
Anita E QuallsDepartment Microbiology and Immunology.
Maria D R Gonzalez-HinojosaDepartment Microbiology and Immunology.
Sarah ObeidallaDepartment Medicine and.
V Eric KerchbergerDepartment Medicine and.ORCID 0000-0002-0342-1965
Tasha TsaoDepartment Medicine.
Jonathan P SingerDepartment Medicine.ORCID 0000-0003-0224-7472
Mark R LooneyDepartment Medicine.
Wilfred RaymondCardiovascular Research Institute, and.
Steven R HaysDepartment Medicine.
Jeffrey A GoldenDepartment Medicine.
Jasleen KukrejaDepartment of Surgery, University of California San Francisco, San Francisco, California.
Ciara M ShaverDepartment Medicine and.
Lorraine B WareDepartment Medicine and.ORCID 0000-0002-9429-4702
Jason ChristieDepartment Medicine and.
Joshua M DiamondDepartment Medicine and.ORCID 0000-0002-3695-4637
Lewis L LanierDepartment Microbiology and Immunology.
John R GreenlandDepartment Medicine.ORCID 0000-0003-1422-8367
Daniel R CalabreseDepartment Medicine.ORCID 0000-0002-0596-3434
University of California, San Francisco · USVanderbilt University Medical Center · USSan Francisco VA Medical Center · USUniversity of Pennsylvania · USCardiovascular Institute Hospital · JPParker Institute for Cancer Immunotherapy · USVanderbilt University · US
Funding
Research BaseP30DK063720 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GERMAN, MICHAEL S · 2003 to 2019
$21.8MLong Term Follow up of the Lung Transplant Outcomes Group CohortU01HL145435 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTIE, JASON D, PALMER, SCOTT M · 2019 to 2025
$10.2MClinical Risk Factors for Primary Graft DysfunctionR01HL087115 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTIE, JASON D · 2007 to 2017
$7.1MNK MemoryR01AI068129 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANIER, LEWIS LEE · 2006 to 2020
$6.0MImmunobiology of the normal and injured lungR35HL161241 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARK ROBERTS LOONEY · 2022 to 2026
$4.2MGenetics of primary graft dysfunctionR01HL081619 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTIE, JASON D · 2007 to 2011
$3.9MFrailty and patient centered outcomes in candidates for lung transplantationR01HL134851 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SINGER, JONATHAN PAUL · 2017 to 2021
$3.4MMechanisms and pathogenicity of SARS-CoV-2-induced neutrophil extracellular trapsR01AI160167 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LOONEY, MARK ROBERTS · 2021 to 2025
$3.1MPeri-operative factors that drive cell-free hemoglobin-mediated primary graft dysfunctionU01HL163303 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ciara M Shaver · 2022 to 2026
$2.3MHaptoglobin 2 variant and endothelial glycocalyx shedding in sepsis-induced ARDSR01HL158906 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WARE, LORRAINE B · 2021 to 2024
$2.3MInnate Immune Mechanisms of Primary Graft Dysfunction after Lung TransplantationR01HL130324 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LOONEY, MARK ROBERTS · 2016 to 2019
$2.2MMechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in SepsisR01HL164937 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WARE, LORRAINE B · 2022 to 2025
$1.7MBLRD VA IK2 BX005301CSRD VA I01 CX002011NHLBI NIH HHS HL151552NHLBI NIH HHS K01 HL157755NHLBI NIH HHS K08 HL136888NHLBI NIH HHS R01 HL081619NHLBI NIH HHS R01 HL087115NHLBI NIH HHS R01 HL130324NHLBI NIH HHS R01 HL134851NHLBI NIH HHS R01 HL151552NHLBI NIH HHS R01 HL158906NHLBI NIH HHS R01 HL164937NHLBI NIH HHS R35 HL161241NHLBI NIH HHS U01 HL145435NHLBI NIH HHS U01 HL163303NIAID NIH HHS R01 AI068129NIAID NIH HHS R01 AI160167NIDDK NIH HHS P30 DK063720NIH HHS AI068129NIH HHS S10 OD021822
Abstract
PubMed holds no abstract for this paper.
Indexed as
Acute Lung InjuryPrimary Graft DysfunctionGenomicsHistocompatibility Antigens Class IHumansNK Cell Lectin-Like Receptor Subfamily KHistocompatibility Antigens Class IKLRK1 protein, humanMICB antigenNK Cell Lectin-Like Receptor Subfamily Kacute lung injuryacute respiratory distress syndromeNK cellsprimary graft dysfunction
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.